Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,189Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12McCarthy Tétrault

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2366932

Filing Date : 2000-04-12

Strength per Unit : 100 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-04-12

Date Granted : 2009-08-25

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2519898

Filing Date : 2004-03-23

Strength per Unit : 100 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-03-23

Date Granted : 2012-07-10

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2366932

Filing Date : 2000-04-12

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-04-12

Date Granted : 2009-08-25

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2519898

Filing Date : 2004-03-23

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-03-23

Date Granted : 2012-07-10

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2366932

Filing Date : 2000-04-12

Strength per Unit : 50 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-04-12

Date Granted : 2009-08-25

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2519898

Filing Date : 2004-03-23

Strength per Unit : 50 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-03-23

Date Granted : 2012-07-10

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2366932

Filing Date : 2000-04-12

Strength per Unit : 70 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-04-12

Date Granted : 2009-08-25

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2519898

Filing Date : 2004-03-23

Strength per Unit : 70 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-03-23

Date Granted : 2012-07-10

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2519898

Filing Date : 2004-03-23

Strength per Unit : 140 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-03-23

Date Granted : 2012-07-10

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Dasatinib

Brand Name : SPRYCEL

Patent Number : 2519898

Filing Date : 2004-03-23

Strength per Unit : 80 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-03-23

Date Granted : 2010-07-10

blank